VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume – What’s Next?

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw unusually-high trading volume on Tuesday . Approximately 110,990 shares changed hands during mid-day trading, a decline of 53% from the previous session’s volume of 233,820 shares.The stock last traded at $85.09 and had previously closed at $86.31.

VanEck Pharmaceutical ETF Price Performance

The firm has a market capitalization of $546.18 million, a PE ratio of 21.04 and a beta of 0.72. The firm has a 50-day simple moving average of $88.27 and a 200-day simple moving average of $92.29.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were given a $0.411 dividend. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date was Friday, December 27th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PPH. Stifel Financial Corp lifted its position in shares of VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock valued at $742,000 after buying an additional 924 shares in the last quarter. Jane Street Group LLC lifted its position in shares of VanEck Pharmaceutical ETF by 124.0% during the 3rd quarter. Jane Street Group LLC now owns 19,436 shares of the company’s stock valued at $1,847,000 after buying an additional 10,759 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of VanEck Pharmaceutical ETF by 1.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock valued at $14,641,000 after buying an additional 2,694 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of VanEck Pharmaceutical ETF by 85.0% during the 2nd quarter. Renaissance Technologies LLC now owns 25,900 shares of the company’s stock valued at $2,369,000 after buying an additional 11,902 shares in the last quarter. Finally, FMR LLC lifted its position in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after buying an additional 212 shares in the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.